Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Overexpression of P-glycoprotein in hepatocellular carcinoma and its clinical implication.

Literature DB >> 11819542

Overexpression of P-glycoprotein in hepatocellular carcinoma and its clinical implication.

Xian-Bing Kong, Zu-Kui Yang, Li-Jian Liang, Jie-Fu Huang, Han-Liang Lin.

Abstract

Entities: Disease Gene

Year: 2000 PMID： 11819542 PMCID： PMC4723582 DOI： 10.3748/wjg.v6.i1.134

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

× No keyword cloud information.

6 in total

1. p-Glycoprotein expression as a predictor of breast cancer recurrence.

Authors: S Gregorcyk; Y Kang; D Brandt; P Kolm; G Singer; R R Perry
Journal: Ann Surg Oncol Date: 1996-01 Impact factor: 5.344

Review 2. MDR1 gene expression in solid tumours.

Authors: L J Goldstein
Journal: Eur J Cancer Date: 1996-06 Impact factor: 9.162

3. Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation.

Authors: Y Y Chou; A L Cheng; H C Hsu
Journal: J Gastroenterol Hepatol Date: 1997-08 Impact factor: 4.029

Review 4. How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.

Authors: M M Gottesman
Journal: Cancer Res Date: 1993-02-15 Impact factor: 12.701

5. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

Authors: K V Chin; K Ueda; I Pastan; M M Gottesman
Journal: Science Date: 1992-01-24 Impact factor: 47.728

6. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.

Authors: J G Park; S K Lee; I G Hong; H S Kim; K H Lim; K J Choe; W H Kim; Y I Kim; T Tsuruo; M M Gottesman
Journal: J Natl Cancer Inst Date: 1994-05-04 Impact factor: 13.506

6 in total

13 in total

1. Expression and bioactivity identification of soluble MG7 scFv.

Authors: Zhao-Cai Yu; Jie Ding; Bo-Rong Pan; Dai-Ming Fan; Xue-Yong Zhang
Journal: World J Gastroenterol Date: 2002-02 Impact factor: 5.742

2. Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of Fas.

Authors: Fang Yin; Yong-Quan Shi; Wei-Ping Zhao; Bing Xiao; Ji-Yan Miao; Dai-Ming Fan
Journal: World J Gastroenterol Date: 2000-10 Impact factor: 5.742

3. P53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resection.

Authors: Lun-Xiu Qin; Zhao-You Tang; Zeng-Chen Ma; Zhi-Quan Wu; Xin-Da Zhou; Qing-Hai Ye; Yuan Ji; Li-Wen Huang; Hu-Liang Jia; Hui-Chuan Sun; Lu Wang
Journal: World J Gastroenterol Date: 2002-06 Impact factor: 5.742

4. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo.

Authors: Fu-Sheng Wang; Ming-Xu Liu; Bing Zhang; Ming Shi; Zhou-Yun Lei; Wen-Bing Sun; Qing-You Du; Ju-Mei Chen
Journal: World J Gastroenterol Date: 2002-06 Impact factor: 5.742

5. Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines.

Authors: B Liu; E Staren; T Iwamura; H Appert; J Howard
Journal: World J Gastroenterol Date: 2001-12 Impact factor: 5.742

6. Expression of liver cancer associated gene HCCA3.

Authors: Z X Wang; G F Hu; H Y Wang; M C Wu
Journal: World J Gastroenterol Date: 2001-12 Impact factor: 5.742

7. Seek protein which can interact with hepatitis B virus X protein from human liver cDNA library by yeast two-hybrid system.

Authors: Xiao-Zhong Wang; Xiang-Rong Jiang; Xiao-Chun Chen; Zhi-Xing Chen; Dan Li; Jian-Yin Lin; Qi-Min Tao
Journal: World J Gastroenterol Date: 2002-02 Impact factor: 5.742